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Purpose: This study was conducted to investigate the effect of Fordyce Happiness Model (FHM) on
depression, stress, anxiety, and fatigue in MS patients.
Methods: In this clinical trial, 140 MS patients assigned to experimental and control groups. Depression,
anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard
Scale before and immediately and three months after the implementation of FHM. The data were
analyzed by SPSS 18.
Results: Independent t-test indicated that total scores of stress, depression, and fatigue of the two groups
were not signiﬁcantly different before the intervention but were signiﬁcantly different after the inter-
vention (P˂0.05). Moreover, anxiety scores of the two were not signiﬁcantly different after the inter-
vention (P˃0.05).
Conclusion: FHM can assist MS patients to manage their disease and associated problems in life. Besides
that, since FHM is efﬁcient and costless, it can be incorporated into the health interventions for MS
patients.
© 2016 Elsevier Ltd. All rights reserved.1. Introduction
Multiple sclerosis (MS) is a prevalent, chronic, progressive, and
central nervous system (CNS)-demyelinating disease in young
adults. MS is more prevalent in young people and is associated with
declined individual and social functions [1]. In the USA, approxi-
mately 500000 people are suffering MS, and 8000 new cases are
diagnosed each year. MS usually develops in people aged 20e40
years. It is the third leading cause of disability in the USA [2]. In Iran,
approximately 50000 people are suffering MS, and MS prevalence
is higher in Isfahan (70/100000 people) [3].
Increasing the number of MS patients necessitates paying
further attention to their treatment-related issues. In addition tox: þ98 38 33346714.
ri), Leila_Rabiei@yahoo.com
alinia), masoodi1383@yahoo.including physical disorders, clinical symptoms and complications
may include a wide range of mental and psychiatric disorders, of
which stress, anxiety, and depression are considered to be most
irritating. Psychological domains of chronic disorders are consis-
tently paid less than adequate attention, such that most scientiﬁc
resources havemainly addressed the neurological symptoms rather
than psychosocial domains of MS [4].
Besides that, stress and anxiety contribute greatly to stimulating
onset of MS attacks and exacerbating associated symptoms. Atarod
and Amanat, 2009 investigated worry level and its Society with
anxiety and depression in MS patients, and reported that the MS
patients were worried about two domains: the effects on physical
activity and the effects, due to the disease severity, on social in-
teractions, family relationships, and daily activities [5].
In addition, depression is one of the most prevalent psychiatric
disorders which is seen in 50%e60% of MS patients [6]. The causes
of depression in MS patients include the treatment course and
unpredictability of MS, recurrent attacks, loss of former capabilities,
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cations. Depression severity may adversely affect quality of life,
physical capabilities, and MS recurrence. In addition, suicide
attempt is closely related to development of depression and
severity of associated symptoms, such that the risk of suicide is
usually 7.7 times higher in MS patients than normal population [7].
Suicidal thinking is 30% prevalent among MS patients in Iran
with suicide attempts being ﬁve times higher than normal popu-
lation [1]. Therefore, depression management has consistently
been one of the main concerns of health care teams.
Fatigue, another prevalent problem in MS patients, refers to a
subjective feeling of lack of physical and mental energy to do and
complete routine and desired activities, which is diagnosed by
caregiver or the patient [4].
Eighty percent of MS patients suffer fatigue and associated
effects on their daily activities, 71% of the patients have been
reported to be absent from work for a number of days, and 28%
to be forced to resign and 75% to change their job or to choose
to leave a higher paying job for a lower one due to severe
fatigue [6].
Regarding the nature of MS and since MS has no deﬁnite
prognosis and can cause long-term problems, non-pharmacological
therapies are strongly recommended. Among non-psychological
therapies, complementary therapies are particularly important to
control and improve disease-associated problems and to promote
quality of life. Besides that, despite inadequate and limited scien-
tiﬁc evidence on the safety and efﬁcacy of complementary thera-
pies, an increasing number of MS patients are using
complementary therapies. Hence, investigating andmonitoring the
efﬁcacy of complementary therapies can be useful. Complementary
therapies are community-oriented and are used to enhance phys-
ical and psychological comfort of patients [8].
Happiness is one of the non-pharmacological therapies that
helps to cope with stress. Happiness is an internal feeling with
natural origin that has external outcomes. Happiness refers to
people's perception of degree or level of desirability of overall
quality of life. Happiness addresses the question “how much does a
person like his/her life?” [9].
Forsberg offered three meanings for health: lack of disease,
personal characteristics, and a state of peace, rehabilitation, and
happiness [10]. Some experts have argued that happiness is the ﬁrst
condition for health development. The people who are happy feel
more secure, take decision more easily, have a more cooperative
spirit, and feel more satisﬁed compared to the people with whom
they are living [11,12].
Happy people enjoy a stronger sense of personal control, are
more likely to think about their capabilities rather than their in-
abilities, and cope with stress more often [13]. Happiness
strengthens immune and cardiovascular systems and improves
health. Lack of happiness is stressful and stress can lead to
dangerous diseases [14].
Lama,2010 have argued that learning happiness is the ﬁrst thing
to do to achieve happiness and hence people can be trained to learn
how to be happy [15]. Fordyce Happiness Model (FHM) is an
approach to train happiness. FHS consists of 14 principles: eight
cognitive principles and six behavioral principles. These principles
include development of healthy personality, removal of concerns,
reduction of expectations andwishes, being the real self, and giving
priority to happiness [16].
Regarding stupendous costs of pharmacotherapies, which is
currently a challenge facing health care systems, adverse side ef-
fects of some drugs, and the adverse effects of depression, anxiety,
stress, and fatigue on quality of life among MS patients, this study
was conducted to investigate the effect of the FHM on depression,
anxiety, stress, and fatigue in MS patients.2. Materials and methods
This clinical trial was conducted in 2015e2016 and registered as
IRCT2014112420064N1 in the Iranian Register of Clinical Trials. The
study population consists the patients referring to the Multiple
Sclerosis Society of Isfahan. The number of participants was esti-
mated to be 63 in each group according to the formula below:
n ¼ 2ðz1 þ z2Þ2  s2=d2 Having predicted 10 dropouts for each
group, we ﬁnally decided to enroll 70 people in each one.
The inclusion criteria were being deﬁnitely diagnosed with MS
and having records in the Society and the exclusion criteria having
history of other psychiatric disorders including major depressive
disorder (according to the medical records and the physician's ex-
aminations) or bipolar disorder (except for cognitive disorders by
which MS is characterized), substance dependency, any neurolog-
ical disorders, history of taking corticosteroids or the disease
recurrence within the previous six months.
Because the patients were not hospitalized and regularly
referred to the Association, to follow randomized assignment, we
decided to run the sampling within two consecutive months until
we enrolled an adequate number of participants. Accordingly, 70
numbers, equal to the number of people required in each group,
were developed and the numbers 1e70 were randomly assigned to
two groups: experimental and control. After eligible patients
referred to the Association, a number was randomly assigned to
each patient according to his/her referring time and the patients
were assigned to the two groups.
The interventionwas implemented within two days a week. For
the control group, a routine protocol was conducted. For blinding,
the patients of the control group referred to the Society on certain
days of week and those of the experimental on other days.
To gather the data, a questionnaire of demographic character-
istics, Depression Anxiety Stress Scale 21 (DASS-21) and Piper Stan-
dard Scalewere used. To investigate depression, anxiety, and stress,
DASS-21, developed by Lovibond and Lovibond in 1995, was used
and its validity and reliability were conﬁrmed [17]. To measure
fatigue, the Piper Standard Scale was used. This scale consists of 27
items that measures fatigue in terms of four domains: behavioral,
affective, tactile, and cognitive. Validity (content and concurrent) of
this scale has already been conﬁrmed [18].
To assess the reliability of the instruments used in this study,
split-half reliability was used. Pearson's correlation coefﬁcient was
estimated to be 0.79 and 0.89 for the half of the DASS-21 and the
Piper Standard Scale, respectively.
After the participants were randomly assigned to the experi-
mental and control groups and pretest was administered, the FHM
was conducted for the experimental group in the room determined
to hold the training sessions. This training programwas conducted
within eight 1- to 1.5-h sessions, two sessions a week through
lecturing, group discussions, and question and answering, such that
the scientiﬁc materials were offered within the ﬁrst half-time of
each session and, after a rest, the group discussions and questioning
and answering were run about the drills of the subject of interest in
the second half-time. At the end of each session, the participants
were asked to run through certain drills empirically outside
research environment.
The intervention consisted of: deﬁning depression, stress, anx-
iety, and their symptoms, deﬁning happiness, and explaining its
necessity, reviewing the results of previous studies on happiness
(the ﬁrst session); the technique of increasing physical activity, the
technique of being productive, and doing useful and meaningful
things (the second session); the principles of planning and better
organization–the technique of removing concerns, the technique of
reducing expectations and wishes (the third session); the tech-
nique of enhancing creativity, the technique of living at present (the
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technique of being the real self (the ﬁfth session).
The technique of increasing intimacy as the most important
source of happiness–the technique of giving priority to happiness
and making it invaluable (the sixth session); the technique of
expressing emotions, the technique of enhancing optimism (the
seventh session); reviewing all the techniques taught, adminis-
tering post-test (the eighth session).
At completion of the training program, all happy techniques
were brieﬂy reviewed with the participants, the participants were
asked some questions about their current happiness and optimism
levels, and their questions, if any, were answered. Then, DASS-21
and Piper Scale were administered to the participants.
The participants were acknowledged for their participation in
the study and the follow-up session was decided to be held three
months later. Moreover, to investigate the efﬁcacy of the FHM, the
DASS-21 and Piper Standard Scale were administered to the exper-
imental group in the follow-up session.
The study protocol was approved by the Tehran University of
Medical Sciences (the Research Project No. 93-02-85-18658 and the
Ethics Code 125899). The researcher started the study after the
Multiple Sclerosis Society provided the formal letter of permission to
conduct the study. The patients were ensured that the data are
analyzed as conﬁdential and anonymous and the ﬁndings are re-
ported in general rather than as case-speciﬁc.
The data obtained before and after conduction of the program
were analyzed by chi-square test, Mann-Whitney, covariance sta-
tistics, repeated measures ANOVA, and independent t-test in SPSS
18.
3. Results
Chi-square test and t-test indicated that there was no signiﬁcant
difference in distribution of age, marital status, education, eco-
nomic status, gender, recurrence frequency, and hospitalization
duration between the two groups, and the two groups were
matched for these variables (P  0.05) (Table 1).
The mean age of the participants was 49.32 ± 6.86 years (48.75
years in the experimental group and 49.81 years in the control
group). Out of the participants, 75.6% were married and 57.62%
were women.
According to independent t-test, there was no signiﬁcant dif-
ference in the stress score between the two groups before the
intervention, but (immediately and three months) after the inter-
vention, there was a signiﬁcant difference in the stress score be-
tween the two groups (P < 0.05). In addition, paired t-test indicated
a signiﬁcant difference in the stress score of the experimental group
between before and (immediately and three months) after the
intervention (P < 0.05), but no corresponding signiﬁcant difference
was seen in the control group (Table 2).
According to independent t-test, there was no signiﬁcant dif-
ference in the anxiety score between the two groups before the
intervention. After (Immediately and three months after) the
intervention, the anxiety score decreased yet insigniﬁcantly
(P > 0.05). According to paired t-test, there was a signiﬁcant dif-
ference in the anxiety score of the experimental group between
before and (immediately and three months) after the intervention
(P > 0.05). In the control group, no corresponding signiﬁcant dif-
ference was seen (Table 2).
Regarding depression, independent t-test indicated that the
depression score was not signiﬁcantly different between the two
groups before the intervention. But, (immediately and three
months) after the intervention, there was a signiﬁcant difference in
the depression score between the two groups (P < 0.05). As well,
paired t-test indicated a signiﬁcant difference in the depressionscore of the experimental group between before and (immediately
and three months) after the intervention (P < 0.05), but in the
control group, no corresponding signiﬁcant difference was
observed (Table 2).
Independent t-test showed that the total score of fatigue was
not signiﬁcantly different between the two groups before the
intervention, but (immediately and three months) after the inter-
vention, a signiﬁcant difference was seen in the total score of fa-
tigue between the two groups (P < 0.001). Paired t-test also
indicated a signiﬁcant difference in the total score of fatigue be-
tween before and (immediately and three months) after the
intervention in the experimental group (P < 0.001), but in the
control group, no corresponding signiﬁcant difference was seen
(Table 3).
4. Discussion
This study demonstrated a signiﬁcant difference in levels of
stress, depression, and total fatigue between before and after the
intervention, representing the optimal effect of FHM in decreasing
the severity of stress, depression, and total fatigue. Regarding
anxiety, however, the difference in the mean score was not signif-
icant between before and after the intervention.
To know that a disease may lead to loss of capabilities leads
frequently to development of stress. It is therefore important to
manage anxiety in MS patients. After three months, the FHM failed
to relieve anxiety signiﬁcantly in the MS patients. Accordingly,
anxiety is considered to be an important issue in MS patients and
combined pharmacological and non-pharmacological in-
terventions are required. Mackereth et al. study, conducted in En-
gland, indicated that progressive muscle relaxation (PMR) was
effective in relieving stress in MS patients [19].
This inconsistency of the ﬁndings can be due to differences in
the studied interventions, health care context, and other underly-
ing factors in the two contexts such as culture, beliefs, and social
support of the patients in copingwith the disease. Ninety percent of
MS patients complain about severe stress and anxiety, and since
these patients are more likely to suffer more severe psychiatric
disorders such as stress and anxiety [20], then anxiety which is
deeply rooted in the feelings and beliefs of MS patients should be
consistently considered a fundamental MS-associated concern by
healthcare system.
Aldridge et al. study to investigate the effect of music therapy, as
a supplementary therapy, on 20 MS patients, demonstrated that
this therapy caused a signiﬁcant difference in the mean scores of
stress and anxiety in four different intervals. Because depression,
stress, and anxiety are closely associated in MS patients, it can be
argued that relieving one of them can be effective in relieving the
other two disorders [21]. The important ﬁnding of the present
study was that the FHM was signiﬁcantly effective in managing
stress, depression, and total fatigue but not anxiety. However, the
total score of anxiety decreased and health planners can manage
anxiety in MS patients more efﬁciently and take more effective
measures to manage this disorder.
Besides that, supplementary therapies have many advantages
for MS patients and are widely administered to these patients.
Approximately 1/3 of MS patients have been reported to use sup-
plementary therapies despite accessing conventional and routine
therapies. Moreover, acceptance of supplementary therapies has
increased in the health care system and non-pharmacological in-
terventions are increasingly used to supplement modern medicine
[22].
Accordingly, the FHM, as an effective supplementary therapy in
managing stress and depression, can be incorporated, as a useful
approach, into health care programs. Relevantly, Bitsko et al. study
Table 1
The patients' demographic characteristics.
Variable Group Scale Frequency percentage Level of signiﬁcance
Age Control Under 30 years 44% P ¼ 0.23
30-60 years 52%
Over 30 years 4%
Experimental Under 30 years 37%
30-60 years 40%
Over 30 years 4%
Marital status Control Single 14.71% P ¼ 0.81
Married 85.29%
Experimental Single 20.58%
Married 71.42%
Education Control Ability to read and write 5.76% P ¼ 0.69
Below high school completion 23.52%
High school completion 35.29%
Higher than high school completion 35.41%
Experimental Ability to read and write 7.70%
Under high school completion 26.47%
High school completion 29.41%
Higher than high school completion 36.41%
Economic status Control Poor 26.47% P ¼ 0.12
Average 38.24%
Good 35.29%
Experimental Poor 29.42%
Average 35.29%
Good 35.29%
Gender Control Female 61.76% P ¼ 0.81
Male 38.24%
Experimental Female 55.88%
Male 44.12%
Frequency of recurrence Control No 54.3% P ¼ 0.94
Once 34.3%
Twice and more 11.4%
Experimental No 42.9%
Once 22.9%
Twice and more 34.52%
Number of hospitalizations Control No 17.14% P ¼ 0.58
Once 30%
Twice 30%
Three times 22.86%
Experimental No 11.43%
Once 38.57%
Twice 21.43%
Three times 28.57%
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depression in 42 adolescents with leukemia in Virginia, the USA,
demonstrated that eight sessions of happiness training caused
decrease in depression symptoms and improvement of quality of
life [23].
The ﬁndings of this study, based on eight sessions of active
learning and the participants' collaboration, are consistent with
Bitsko et al. study. It appears that that the programs developed
within a larger number of sessions are more likely to lead to loadingTable 2
Mean scores of stress, anxiety, and depression in patients with multiple sclerosis for For
Variables Time Experimental group
Mean Standard
Anxiety Before intervention 16.94 (2.41)
Immediately after intervention 14.96 (2.97)
Three months after intervention 14.93 (2.81)
Repeated measures ANOVA 0.007
Stress Before intervention 14.88 (2.5)
Immediately after intervention 13.87 (2.97)
Three months after intervention 13.57 (3.81)
Repeated measures ANOVA 0.011
Depression Before intervention 14.57 (2.54)
Immediately after intervention 12.96 (1.96)
Three months after intervention 12.66 (2.59)
Repeated measures ANOVA 0.003higher rates of happiness and more stable outcomes, and conse-
quently more reliable results. Importantly, this program can be
effective in patients with diseases rather than MS.
Being happy can explain approximately 95.5% of quality of life in
MS patients. Psychological dimension is one of the dimensions of
quality of life. Studies have conﬁrmed decreased symptoms of
psychiatric disorders with increased living a happy life in the pa-
tients, such that the patients that live a happy life have ﬂexibility.
Furthermore, the interventions lead to enhancing happiness anddyce Happiness Model at different times in the experimental and control groups.
Control group Independent t-test
deviation Mean Standard deviation
16.11 (1.95) 0.12
16.26 (2.76) 0.07
16.08 (2.53) 0.084
0.93
15.05 (2.08) 0.75
15.06 (2.55) 0.09
14.97 (2.89) 0.1
0.98
14.25 (2.45) 0.6
14.08 (2.46) 0.044
14.06 (1.98) 0.016
0.99
Table 3
Mean score of patients with multiple sclerosis for Fordyce Happiness Model at different times in the experimental and control groups.
Fatigue domains Time Groups t-test
Experimental Control
Behavioral Before intervention 4.35 4.68 P > 0.05
Immediately after intervention 3.17 5.12 P ¼ 0.037
Three months after intervention 3.10 5.38 P ¼ 0.02
Repeated measures ANOVA P < 0.001 0.67
Affective Before intervention 4.72 4.58 P > 0.05
Immediately after intervention 3.79 5.14 P ¼ 0.03
Three months after intervention 3.31 5.51 P ¼ 0.006
Repeated measures ANOVA P ¼ 0.001 P ¼ 0.71
Tactile Before intervention 4.25 99/4 P > 0.05
Immediately after intervention 3.76 5.29 P ¼ 0.01
Three months after intervention 3.22 4.47 P < 0.001
Repeated measures ANOVA P < 0.001 0.58
Cognitive Before intervention 2.66 2.86 P > 0.05
Immediately after intervention 2.34 3.73 P ¼ 0.06
Three months after intervention 2.29 3.61 P ¼ 0.021
Repeated measures ANOVA 0.011 0.48
Total fatigue Before intervention 6.25 6.60 P > 0.05
Immediately after intervention 4.45 6.87 P ¼ 0.012
Three months after intervention 4.33 6.81 P ¼ 0.007
Repeated measures ANOVA <0.001 0.81
F. Khayeri et al. / Complementary Therapies in Clinical Practice 25 (2016) 130e135134alleviating certain diseases such as epilepsy, Huntington's disease,
MS, Parkinson's disease, and stroke [24].
Liubomirsky et al. argued that the conditions and response to
accidents are more appropriate in happy and optimist people.
These people cope with stressful conditions more efﬁciently, have a
stronger immune system, and deal with issues and incidents more
creatively. Therefore, they manage stress more efﬁciently and ac-
quire stress less often [25]. Because MS is a disorder of immune
system, the FHM helped to moderate the psychiatric disorders in
the patients through affecting their immune system.
The signiﬁcance and role of happiness should be seriously
considered in health issues. Fitzgerald et al. study demonstrated
that happiness is 32% correlated with health. Mental health is a
component of happy life and is not the same as physical health.
Moreover, happiness and acquisition of rare disease are somehow
associated particularly if the disease causes restrictions in doing
individual activities [26]. In fact, disease-induced depression is due
to loss of mental health which is somehow concurrent with loss of
happiness. Addressing happiness in MS patients may lead to
reduced acquisition of depression and other psychiatric andmental
disorders in these patients.
Fatigue is another clinical symptom of MS which is largely
associated with quality of life in MS patients and is seen in 67%e
95% of them. Approximately 50%e60% of these patients consider
fatigue to be the worst symptom of MS and 15%e40% consider it to
be the most debilitating one [27]. Moreover, in a study on MS-
associated disability, 81% of the patients reported to suffer fa-
tigue, such that patients with higher levels of fatigue suffered
higher levels of disability and had a lower quality of life [6].
In terms of management of the MS-induced problems such as
fatigue, optimistic attitude is an important point. Optimist attitude
can stop all serious suffering and concerns in the patient, increase
longevity, slow down the course of MS, reduce the attacks, and
delay the onset of permanent disability [28]. This study showed
that supplementary therapies, such as FHM, may remove many
fatigue-induced problems in the patients throughout the course of
MS and assist them in living with MS.
In this regard, McCallugh et al. study on long-term exercise ef-
fect on quality of life and fatigue in MS patients with mild disability
indicated that after a three-month period of exercise, fatigue
improved considerably, but after six months of exercise, quality of
life changed signiﬁcantly [29]. It is therefore very important toaddress quality of life in MS patients with emphasis on certain
symptoms such as stress, anxiety, and depression alongside fatigue,
as in this study, these symptoms were investigated and the ﬁnal
outcome, i.e. quality of life, was seen to improve after imple-
mentation of the FHM.
Dayapogu et al. study on the PMR effect on fatigue and quality of
life in MS patients, demonstrated that quality of life and fatigue
signiﬁcantly improved [30], which is consistent with the present
study.
Masoudi et al. conducted a randomized clinical trial to investi-
gate the efﬁcacy of a PMR technique in relieving pain in MS pa-
tients, and found no signiﬁcant difference in the severity of
subjectively perceived pain between experimental and control
groups before intervention, while the intervention caused a sig-
niﬁcant difference in the corresponding pain between the two
groups. Although Masoudi et al. investigated the severity of sub-
jectively perceived pain, consistent with the present study, they
indicated optimal effects of supplementary therapies on the com-
plications and symptoms of MS [1].
We recommend further studies be conducted on supplementary
therapies, alongside pharmacotherapies, and patients with MS and
other diseases who are predisposed to speciﬁc mental disorders.
Regarding these ﬁndings, we can argue that implementing FHM,
aimed to improve peace and satisfaction in MS patients, can lead to
positive effects. MS is a disease that may cause certain restrictions,
including environmental, economic, human, and time-related, and
special psychiatric conditions, and FHM is an approach that may
greatly help to improve their quality of life.
5. Conclusion
According to this study, the FHM was effective in relieving
depression, stress, fatigue, and to some extent, anxiety. Because of
being implemented easily, being safe and accessible, causing no risk
to the patient and his/her family as well as no costs, which is
currently one of the concerns of health care system, FHM is rec-
ommended to be conducted on patients with psychiatric disorders
especially MS.
Acknowledgments
We gratefully thank the MS patients for their warm and sincere
F. Khayeri et al. / Complementary Therapies in Clinical Practice 25 (2016) 130e135 135cooperation with this study despite many problems, speciﬁc to
patients with chronic diseases, they faced.
References
[1] R. Masoudi, A. Shariﬁ Faradonbeh, M. Mobasheri, J. Moghadasi, Evaluating the
effectiveness of using a progressive muscle relaxation technique in reducing
the pain of multiple sclerosis patients, J. Musculoskelet. Pain 21 (4) (2013)
350e357.
[2] R. Masoudi, H. Abedi, P. Abedi, S.E. Mohammadianinejad, The perspectives of
Iranian patients with multiple sclerosis on continuity of care: a qualitative
study, J. Nurs. Res. 23 (2) (2015) 145e152.
[3] R. Masoudi, H.A. Abedi, P. Abedi, S.E. Mohammadianinejad, Iranian family
caregivers' challenges and issues in caring of multiple sclerosis patients: a
descriptive explorative qualitative study, Iran. J. Nurs. Midwifery Res. 19 (4)
(2014) 416.
[4] X. Liu, H. Ye, W. Li, R. Dai, D. Chen, M. Jin, Relationship between psychosocial
factors and onset of multiple sclerosis, Eur. Neurol. 62 (3) (2009) 130e136.
[5] S. Atarod, S. Amanat, Attitude of patients with MULTIPLE SCLEROSIS towards
the impacts of the disease on their social and sexual activities, J. Res. Behav.
Sci. 6 (2) (2009).
[6] M. Asano, M.L. Finlayson, Meta-analysis of three different types of fatigue
management interventions for people with multiple sclerosis: exercise, edu-
cation, and medication, Mult. Scler. Int. (2014) 12, http://dx.doi.org/10.1155/
2014/798285. Article ID 798285.
[7] T. Kirchner, S. Lara, Stress and depression symptoms in patients with multiple
sclerosis: the mediating role of the loss of social functioning, Acta Neurol.
Scand. 123 (6) (2011) 407e413.
[8] V. Yadav, C. Bever, J. Bowen, A. Bowling, B. Weinstock-Guttman, M. Cameron,
et al., Summary of evidence-based guideline: complementary and alternative
medicine in multiple sclerosis report of the guideline development subcom-
mittee of the American academy of neurology, Neurology 82 (12) (2014)
1083e1092.
[9] L. Rabiei, M.A. Mazaheri, R. Masoudi, S.A.M. Hasheminia, Fordyce happiness
program and postpartum depression. Journal of research in medical sciences,
Off. J. Isfahan Univ. Med. Sci. 19 (3) (2014) 251.
[10] A. Forsberg, Y. Nilsagård, K. Bostr€om, Perceptions of using videogames in
rehabilitation: a dual perspective of people with multiple sclerosis and
physiotherapists, Disabil. Rehabilitation 37 (4) (2015) 338e344.
[11] W. Hofmann, M. Luhmann, R.R. Fisher, K.D. Vohs, R.F. Baumeister, Yes, but are
they happy? Effects of trait self-control on affective well-being and life
satisfaction, J. Personality 82 (4) (2014) 265e277.
[12] H.S. Friedman, M.L. Kern, Personality, well-being, and health*, Psychology 65
(1) (2014) 719.
[13] A. Sanchez, C. Vazquez, Looking at the eyes of happiness: positive emotions
mediate the inﬂuence of life satisfaction on attention to happy faces, J. Posit.Psychol. 9 (5) (2014) 435e448.
[14] D. Carr, V.A. Freedman, J.C. Cornman, N. Schwarz, Happy marriage, happy Life?
Marital quality and subjective well-being in later life, J. Marriage Fam. 76 (5)
(2014) 930e948.
[15] H.D. Lama, The Art of Happiness: A Handbook for Living, Hachette, UK, 2010.
[16] B. Schrank, T. Brownell, A. Tylee, M. Slade, Positive psychology: an approach to
supporting recovery in mental illness, East Asian Archives Psychiatry 24 (3)
(2014) 95.
[17] P.F. Lovibond, S.H. Lovibond, The structure of negative emotional states:
comparison of the depression anxiety stress scales (DASS) with the beck
depression and anxiety inventories, Behav. Res. Ther. 33 (3) (1995) 335e343.
[18] R. Masoudi, F. Kheiri, F. Ahmadi, I. Mohammadi, The effect of self-care pro-
gram base on the Orem frame work on fatigue and activity of daily living in
multiple sclerosis patients, J. Rehabilitation 10 (3) (2009) 1e10.
[19] P.A. Mackereth, K. Booth, V.F. Hillier, A.-L. Caress, Reﬂexology and progressive
muscle relaxation training for people with multiple sclerosis: a crossover trial,
Complementary Ther. Clin. Pract. 15 (1) (2009) 14e21.
[20] A. Beiske, E. Svensson, I. Sandanger, B. Czujko, E. Pedersen, J. Aarseth, et al.,
Depression and anxiety amongst multiple sclerosis patients, Eur. J. Neurology
15 (3) (2008) 239e245.
[21] D. Aldridge, W. Schmid, M. Kaeder, C. Schmidt, T. Ostermann, Functionality or
aesthetics? A pilot study of music therapy in the treatment of multiple scle-
rosis patients, Complementary Ther. Med. 13 (1) (2005) 25e33.
[22] L. Shinto, S. Sinsheimer, D. Bourdette, Complementary therapies in multiple
sclerosis, Integr. Med. 4 (6) (2005) 30e37.
[23] M.J. Bitsko, M. Stern, R. Dillon, E.C. Russell, J. Laver, Happiness and time
perspective as potential mediators of quality of life and depression in
adolescent cancer, Pediatr. Blood Cancer 50 (3) (2008) 613e619.
[24] Y. Barak, A. Achiron, Happiness and personal growth are attainable in
interferon-beta-1a treated multiple sclerosis patients, J. Happiness Stud. 12
(5) (2011) 887e895.
[25] S. Lyubomirsky, K. Layous, How do simple positive activities increase well-
being? Curr. Dir. Psychol. Sci. 22 (1) (2013) 57e62.
[26] C.J. Fitzgerald, K.M. Danner, Evolution in the ofﬁce: how evolutionary psy-
chology can increase employee health, happiness, and productivity, Evol.
Psychol. 10 (5) (2012), 147470491201000502.
[27] G. Salehpoor, S.M. Kaﬁ, S. Rezaei, M. Hosseininezhad, I. Salehi, The relation
between fatigue severity with psychological symptoms and quality of life in
multiple sclerosis, Zahedan J. Res. Med. Sci. 14 (9) (2012) 80e86.
[28] L.B. Krupp, D.J. Seraﬁn, C. Christodoulou, Multiple sclerosis-associated fatigue,
Expert Rev. Neurother. 10 (9) (2010) 1437e1447.
[29] R. McCullagh, A.P. Fitzgerald, R.P. Murphy, G. Cooke, Long-term beneﬁts of
exercising on quality of life and fatigue in multiple sclerosis patients with
mild disability: a pilot study, Clin. Rehabil. 22 (3) (2008) 206e214.
[30] N. Dayapoglu, M. Tan, Evaluation of the effect of progressive relaxation ex-
ercises on fatigue and sleep quality in patients with multiple sclerosis,
J. Altern. Complementary Med. 18 (10) (2012) 983e987.
